Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 45,243 | 37,605 | 62,756 | 32,608 | 29,766 |
| Operating Income | -45,243 | -37,605 | -62,756 | -32,608 | -29,766 |
| Other Income | 6,060 | 5,391 | 4,615 | 3,662 | 2,353 |
| Pre-tax Income | -39,183 | -32,214 | -58,141 | -28,946 | -27,413 |
| Income Tax | N/A | N/A | N/A | -1,858 | -2,523 |
| Net Income Continuous | -39,183 | -32,214 | -58,141 | -27,088 | -24,890 |
| Minority Interests | N/A | N/A | -179 | -306 | -86 |
| Net Income | $-39,183 | $-32,214 | $-57,962 | $-26,782 | $-24,804 |
| EPS Basic Total Ops | -0.91 | -0.82 | -1.42 | -0.63 | -0.54 |
| EPS Basic Continuous Ops | -0.92 | -0.81 | -1.43 | -0.63 | -0.55 |
| EPS Diluted Total Ops | -0.91 | -0.82 | -1.42 | -0.58 | -0.54 |
| EPS Diluted Continuous Ops | -0.92 | -0.81 | -1.43 | -0.58 | -0.55 |
| EBITDA(a) | $-45,163 | $-37,524 | $-62,684 | $-32,549 | $-29,757 |